Christopher D. Ganser, VP - Regulatory Sciences at BARD C R INC /NJ/ (BCR), sold 22,200 shares at $73.85 ($1.6M) on 2006-05-01, disclosed to the SEC on 2006-05-02.
Open-market sale of $1.6M BCR by VP - Regulatory Sciences. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $73.85 | 19,900 | $1.5M | 89.6% |
| 2 | $74.10 | 1,700 | $126K | 7.7% |
| 3 | $74.11 | 600 | $44K | 2.7% |
| Total | $73.88 avg | 22,200 | $1.6M | 100% |